We present our experience with 10 liver transplant recipients in whom
cryptococcal meningitis developed after liver transplantation. Disease
developed a median period of 3.5 months (range, 2-36 months) after tr
ansplantation and patients were diagnosed a median period of 9 days (r
ange, 2-90 days) after initial symptoms. Headache, fever, and mental s
tatus changes were the most frequent clinical presentations, while men
ingismus was found in only 30% of patients. Cerebrospinal fluid analys
is was diagnostic in all cases. All patients were treated with amphote
ricin B and flucytosine. Immunosuppression was either decreased or dis
continued during therapy. Five patients died, four as a direct result
of cryptococcal infection and one as a result of chronic rejection. Th
ree patients had long-term survival without any sequelae. One long-ter
m survivor suffered blindness consequent to the disease, We conclude t
hat cryptococcal meningitis is a rare complication in liver transplant
recipients (0.25%), and has a high mortality rate (50%), Early recogn
ition, combination antifungal therapy, and decrease or discontinuation
of immunosuppression are important for cure. No relapse has been seen
in surviving patients.